Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Southern medical journal (Birmingham, Ala. Print)

• Publication date

  2015-09-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.14423/SMJ.0000000000000343PMID 26332483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers

  2014cited by this paper
• Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.

  2014cited by this paper
• Association of response to hepatitis B vaccination and survival in dialysis patients

  2012cited by this paper
• ‘Time and Time Again’: Oscillatory and Longitudinal Time Patterns in Dialysis Patients

  2012influential reference
• Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.

  2011cited by this paper
• Response to hepatitis B vaccine differs by birthweight among neonates.

  2011cited by this paper
• Interleukin-18 Promoter Polymorphism and Development of Antibodies to Surface Antigen of Hepatitis B Virus in Hemodialysis Patients

  2011cited by this paper
• Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients.

  2011cited by this paper
• The spectrum of infections in catheter-dependent hemodialysis patients.

  2011cited by this paper
• Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy.

  2011cited by this paper
• Review article: Hepatitis B and dialysis

  2010cited by this paper
• The burden of obesity on infectious disease

  2010cited by this paper
• Clinical and cost effectiveness of guidelines to prevent intravascular catheter-related infections in patients on hemodialysis.

  2010cited by this paper
• Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007

  2009cited by this paper
• Efficacy and long‐term immunogenicity of hepatitis B vaccine in haemodialysis patients

  2009cited by this paper
• Hepatitis C Virus Transmission in Hemodialysis Units Importance of Infection Control Practices and Aseptic Technique

  2009cited by this paper
• Transmission of hepatitis B virus (genotype E) in a haemodialysis unit.

  2007cited by this paper
• Definition of needle length required for intramuscular deltoid injection in elderly adults: an ultrasonographic study.

  2006cited by this paper
• Increasing body mass index and obesity in the incident ESRD population.

  2006cited by this paper
• Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients

  2005cited by this paper
• Factors Associated with Long‐Term Antibody Production Induced by Hepatitis B Vaccine in Patients Undergoing Hemodialysis: A Retrospective Cohort Study

  2003cited by this paper
• Estimating the relative risk in cohort studies and clinical trials of common outcomes.

  2003cited by this paper
• Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.

  2003cited by this paper
• Efficient Haemodialysis Improves the Response to Hepatitis B Virus Vaccination

  2002cited by this paper
• New national surveillance system for hemodialysis-associated infections: initial results.

  2002cited by this paper
• The effect of late doses on the achievement of seroprotection and antibody titer levels with hepatitis b immunization among adolescents.

  2001cited by this paper
• Nosocomial Spread of Hepatitis B Virus in Two Hemodialysis Units, Investigated by Restriction Fragment Length Polymorphism Analysis

  2000cited by this paper
• The immune system in the elderly: II. Specific cellular immunity.

  1999cited by this paper
• Hepatitis B Vaccine Administered to Children and Adolescents at Yearly Intervals

  1999cited by this paper
• The immune system in the elderly: I. Specific humoral immunity.

  1999cited by this paper
• Recursive partitioning in the health sciences

  1999cited by this paper
• Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.

  1998cited by this paper
• Hepatitis C virus infection in dialysis and renal transplantation.

  1997cited by this paper
• Determination of deltoid fat pad thickness. Implications for needle length in adult immunization.

  1997cited by this paper
• Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination.

  1996cited by this paper
• Weight, height and body mass index distributions in geographically and ethnically diverse samples of older persons. Ad Hoc Committee on the Statistics of Anthropometry and Aging.

  1996cited by this paper
• Transmission of HIV in dialysis centre.

  1995cited by this paper
• Hepatitis B vaccine responsiveness in Connecticut public safety personnel.

  1993cited by this paper
• Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.

  1993cited by this paper
• Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients.

  1992cited by this paper
• Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection.

  1992cited by this paper
• Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.

  1987cited by this paper
• Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States.

  1986cited by this paper
• Impaired immunogenicity of hepatitis B vaccine in obese persons.

  1986cited by this paper
• Impaired immunogenicity of hepatitis B vaccine in obese persons.

  1986cited by this paper
• Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.

  1984cited by this paper
• Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

  1984cited by this paper
• The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

  1982cited by this paper
• A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report

  1981cited by this paper

• Seroprotection achieved with standard four-dose schedule of hepatitis B vaccine in people with chronic kidney disease: A real-life data

  2024cites this paper
• Prevalence and predictors of non-response to hepatitis B vaccination among dialysis patients

  2024cites this paper
• Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients

  2023cites this paper
• Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case–Control Pilot Study

  2022cites this paper
• ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis

  2022cites this paper
• STIKO-Empfehlung zur COVID-19-Impfung bei Personen mit Immundefizienz (ID)

  2021cites this paper
• Hepatitis B virus vaccine and chronic kidney disease. The advances.

  2021cites this paper
• Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

  2021cites this paper
• Hepatitis B virus vaccine and chronic kidney disease. The advances.

  2021cites this paper
• Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis

  2019cites this paper
• Vaccination practices in dialysis patients: A narrative review

  2018cites this paper
• Immune response to hepatitis B vaccine among north Iranian healthcare workers and its related factors.

  2017cites this paper
• Antibodies to hepatitis B virus surface antigen and survival of hemodialysis patients – a prospective study

  2016cites this paper
• Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients.

  2016cites this paper